These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias. Occhetta E; Bortnik M; Magnani A; Francalacci G; Marino P Europace; 2006 Oct; 8(10):863-9. PubMed ID: 16916859 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Bollmann A; Husser D; Cannom DS Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia. Roses-Noguer F; Jarman JW; Clague JR; Till J Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999 [TBL] [Abstract][Full Text] [Related]
9. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators. Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190 [TBL] [Abstract][Full Text] [Related]
10. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator. Kelly PA; Mann DE; Damle RS; Reiter MJ J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509 [TBL] [Abstract][Full Text] [Related]
11. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia. Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696 [TBL] [Abstract][Full Text] [Related]
12. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011 [TBL] [Abstract][Full Text] [Related]
13. [Electrical storm in ICD patients: prevention and treatment]. Zarse M; Bogossian H; Lemke B Herzschrittmacherther Elektrophysiol; 2014 Jun; 25(2):66-72. PubMed ID: 24823469 [TBL] [Abstract][Full Text] [Related]
14. Evidence rather than costs must guide use of the implantable cardioverter defibrillator. Delacretaz E; Schlaepfer J; Metzger J; Fromer M; Kappenberger L Am J Cardiol; 2000 Nov; 86(9A):52K-57K. PubMed ID: 11084101 [TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias. Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773 [TBL] [Abstract][Full Text] [Related]